Sonoma Pharmaceuticals Inc Share Price

NASDAQ: SNOA

Small Cap

$4.21

-0.22

(-4.97%)

as on September 17, 2025 at 1:29 am IST

$₹

Sonoma Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$3.8
Day's Price Range
$4.28
$4.21
9.74%
Downside
1.66%
Upside
52 Week's Low
52 Week's High
$1.75
52-Week Price Range
$6.92
$4.21
58.43%
Downside
64.37%
Upside

Sonoma Pharmaceuticals Inc share price movements today

Previous Close: $4.43
Open: $3.81
Volume: 332.8K
Day's Low - High: $3.8 - $4.28
52 Week Low - High: $1.75 - $6.92

Sonoma Pharmaceuticals Inc Historical Returns

1 Month Return: -21.5 %
3 Month Return: + 42.37 %
1 Year Return: -19.23 %
3 Year Return: -92.88 %
5 Year Return: -97.19 %

Sonoma Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Sonoma Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.3M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-3.5M

Revenue (TTM)

14.9M

Profit Margin

-23.84%

Return On Equity TTM

526100.00%

Sonoma Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sonoma Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sonoma Pharmaceuticals Inc	BUY	$7.3M	-97.19%	NA	-23.84%
United Therapeutics Corporation	BUY	$18.0B	NA	15.52	40.36%
Haleon Plc Spon Ads	BUY	$44.0B	NA	21.51	13.81%
Neurocrine Biosciences Inc.	BUY	$14.0B	38.31%	41.69	13.88%
Zoetis Inc.	BUY	$65.4B	-8.86%	25.38	27.83%

Stock Returns calculator for Sonoma Pharmaceuticals Inc Stock including INR - Dollar returns

The Sonoma Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sonoma Pharmaceuticals Inc investment value today

Current value as on today

₹85,829

Returns

₹14,171

(-14.17%)

Returns from Sonoma Pharmaceuticals Inc Stock

₹19,038 (-19.04%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Sonoma Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Sonoma Pharmaceuticals Inc. Average target price of $13.4

Sonoma Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Sonoma Pharmaceuticals Inc.

What analysts predicted

68.58%UPSIDE

Target Price

$13.4

Current Price

$4.21

Analyzed by

7 Analysts

Target

$13.40

Sonoma Pharmaceuticals Inc target price $13.4, a slight upside of 68.58% compared to current price of $4.21. According to 7 analysts rating.

Sonoma Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Sonoma Pharmaceuticals Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-55% versus previous 30 day period

Sonoma Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	3	2	3	3	3	3	3	3	4
Gross Profit	0	1	0	1	1	1	1	1	1	1
Operating Income	-1	-1	-1	0	-1	-1	0	-1	0	-1
EBITDA	-1	-1	-1	0	-1	-1	0	0	0	-1
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	0	-1	0	0	0	0	-1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-1	-1	-1	0	-1	-1	0	0	0	-1
Net Profit Margin	-43.40%	-41.38%	-54.34%	-27.60%	-31.03%	-33.71%	-17.04%	-26.04%	-20.67%	-30.91%

Sonoma Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Revenue	15	12	16	18	18	18	12	13	12	14
Gross Profit	7	5	7	8	8	6	3	4	4	5
Operating Income	-10	-12	-14	-11	-6	-3	-5	-4	-4	-3
EBITDA	-14	-12	-13	-10	-3	-3	-5	-4	-4	-3
Interest Expense	0	0	0	0	0	0	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-10	-12	-14	-11	-2	-3	-5	-5	-5	-2
Income Tax Expense	0	-4	0	0	0	0	0	0	0	0
Net Income	-10	9	-14	-11	-2	-3	-5	-5	-4	-3
Net Profit Margin	-67.37%	72.31%	-86.01%	-62.19%	-15.56%	-21.20%	-40.28%	-38.81%	-37.97%	-24.20%

Sonoma Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jun 2025
Net Income	-1	-1	0	-1	-1	0	0	-1
Operating Cash Flow	0	-1	-1	0	0	0	0	-2
Investing Cash Flow	0	0	0	0	0	0	0	0
Financing Cash Flow	0	0	1	0	0	1	0	0
Change in Cash	0	-1	0	0	0	1	1	-1

Sonoma Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Income	9	-14	-11	-2	-3	-5	-5	-4	-3
Operating Cash Flow	-8	-12	-11	-4	-3	-4	-6	-2	0
Investing Cash Flow	18	0	0	3	0	0	0	0	0
Financing Cash Flow	0	5	5	1	3	7	2	1	3
Change in Cash	9	-7	-6	0	0	3	-3	0	2

Global Institutional Holdings in Sonoma Pharmaceuticals Inc

Funds	Holdings
Geode Capital Management, LLC	1.02%
HRT FINANCIAL LLC	0.72%
UBS Group AG	0.11%
Tower Research Capital LLC	0.09%
Citigroup Inc	0.05%

See all

Insights on Sonoma Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 3.56M → 4.01M (in $), with an average increase of 5.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 16.8% return, outperforming this stock by 31.6%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 84.8% return, outperforming this stock by 177.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, SNOA stock has moved down by -5.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -776.0K → -1.24M (in $), with an average decrease of 59.9% per quarter

About Sonoma Pharmaceuticals Inc

sonoma pharmaceuticals, inc., develops and produces stabilized hypochlorous acid (hocl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the united states and internationally. the company offers epicyn, an antimicrobial facial cleanser; levicyn, a hypochlorous acid (hocl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; celacyn gel, a product indicated to promote healing through the management of new and old scars resulting from surgical procedures and trauma wounds or burns; sebuderm, a product indicated to manage and relieve the burning, itching, pain, and distraction associated with seborrhea and seborrheic dermatitis; and ceramax, a lipogrid based skin barrier cream for management of dry itchy skin, minor skin irritations, rashes, and inflammation caused by various skin conditions, as well as loyon for the management of skin scal

Organisation	Sonoma Pharmaceuticals Inc
Headquarters	5445 Conestoga Court, Boulder, CO, United States, 80301
Industry	Health Technology
CEO	Ms. Amy M. Trombly Esq., J.D.
E-voting on shares	Click here to vote

Key Management of Sonoma Pharmaceuticals Inc

Name	Title
Mr. John Dal Poggetto	Controller
Ms. Amy M. Trombly Esq., J.D.	CEO, President & Director
Mr. Jerome J. Dvonch CPA	Chief Financial Officer
Mr. Bruce Thornton	Executive VP, COO & Corporate Secretary

FAQs

What is Sonoma Pharmaceuticals Inc share price today?

Sonoma Pharmaceuticals Inc share price today is $4.21 as on September 17, 2025 at 1:29 am IST at the close of the market. Sonoma Pharmaceuticals Inc share today touched a day high of $4.28 and a low of $3.8.

What is the 52 week high and 52 week low for Sonoma Pharmaceuticals Inc share?

Sonoma Pharmaceuticals Inc share touched a 52 week high of $6.92 on August 14, 2025 and a 52 week low of $1.75 on April 7, 2025. Sonoma Pharmaceuticals Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $4.21,which is 39.16% down from its 52 week high and 140.57% up from its 52 week low.

What is Sonoma Pharmaceuticals Inc's market capitalisation today?

Sonoma Pharmaceuticals Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Sonoma Pharmaceuticals Inc Stock (SNOA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sonoma Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sonoma Pharmaceuticals Inc Shares that will get you 0.3563 shares as per Sonoma Pharmaceuticals Inc share price of $4.21 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sonoma Pharmaceuticals Inc Stock (SNOA) from India?

Indian investors can start investing in Sonoma Pharmaceuticals Inc (SNOA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 2:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Sonoma Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 2:40 pm IST). Based on Sonoma Pharmaceuticals Inc share’s latest price of $4.21 as on September 17, 2025 at 1:29 am IST, you will get 2.3753 shares of Sonoma Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Sonoma Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Sonoma Pharmaceuticals Inc stock has given -97.19% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?